New HuBMAP Cooperative Agreement Opportunities

The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) aims to develop a framework for functional mapping the human body with cellular resolution to enhance our understanding of cellular organization-function. HuBMAP will accelerate the development of the next generation of tools and techniques to generate 3D tissue maps using validated high-content, high-throughput imaging and omics assays, and establish an open data platform for integrating, visualizing data to build multi-dimensional maps.

New R01 Grants for Cancer Nanotechnology

NCI’s Office of Cancer Nanotechnology Research has published a new funding opportunity announcement for the Innovative Research in Cancer Nanotechnology (IRCN) initiative, PAR-17-240. All IRCN awards made through this announcement will be part of the Alliance for Nanotechnology in Cancer network. Due dates are twice per year, with the announcement remaining open until May 2020. The first due date is November 21, 2017.

Development of Innovative Cancer Diagnostic Devices

In direct response to Vice President Biden’s Cancer Moonshot, Atlanta-based Global Center for Medical Innovation (GCMI) and T3 Labs are collaborating with the National Cancer Institute (NCI) to accelerate development of innovative cancer diagnostic devices from the lab to the marketplace.  This collaboration seeks to maximize the value of taxpayer investments through a cost-effective platform for designing, engineering, and testing diagnostic technologies.